Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 10/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | NOTCH1 | P46531 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.41 |
| ▸ | CETP | P11597 | 2/20 | 0.38 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.37 |
| ▸ | YAP1 | P46937 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6834695 | 1.00 | GPR119 (0.42) | GPR119KDM4EPKMNOTCH1MGLL | |
| SCHEMBL6831982 | 0.92 | NOTCH1 (0.41) | GPR119KDM4EPKMNOTCH1MGLL | |
| SCHEMBL6831983 | 0.92 | NOTCH1 (0.41) | GPR119KDM4EPKMNOTCH1MGLL | |
| SCHEMBL6829137 | 0.82 | P2RY14 (0.39) | — | |
| SCHEMBL6829134 | 0.82 | P2RY14 (0.39) | — | |
| SCHEMBL27459780 | 0.81 | MGLL (0.44) | GPR119KDM4EPKMNOTCH1MGLL | |
| SCHEMBL6831986 | 0.80 | KDM4E (0.48) | GPR119KDM4EPKMNOTCH1MGLL | |
| SCHEMBL5775684 | 0.76 | KDM4E (0.57) | GPR119KDM4EPKMTGFBR1 | |
| SCHEMBL6832722 | 0.75 | PLAU (0.38) | — | |
| SCHEMBL6750024 | 0.74 | NOTCH1 (0.44) | GPR119KDM4EPKMNOTCH1MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040072866-A1 | Process for preparation of cyanophenylbenzoic acid derivatives | TEIJIN LIMITED (JP) | 2004-04-15 | — | — | US | claimed |
| EP-1361213-A1 | PROCESS FOR PREPARATION OF CYANOPHENYLBENZOIC ACID DERIVATIVES | TEIJIN LIMITED (JP) | 2003-11-12 | — | — | EP | claimed |
| US-20040072866-A1 | Process for preparation of cyanophenylbenzoic acid derivatives | TEIJIN LIMITED (JP) | 2004-04-15 | — | — | US | disclosed |
| EP-1361213-A1 | PROCESS FOR PREPARATION OF CYANOPHENYLBENZOIC ACID DERIVATIVES | TEIJIN LIMITED (JP) | 2003-11-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040072866-A1 | Process for preparation of cyanophenylbenzoic acid derivatives | CCNY, ACLY, IWS1 | GPR119 3726/4885KDM4E 522/4885PKM 567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.